These Analysts Slash Their Forecasts On Teladoc Health After Q4 Results

Financial Performance - Teladoc Health reported a quarterly loss of 14 cents per share, which was better than market estimates of a loss of 18 cents per share [1] - The company's sales for the quarter reached $642.269 million, exceeding estimates of $635.235 million [1] - For FY2026, Teladoc Health anticipates a GAAP loss in the range of $(1.10) to $(0.70), compared to market estimates of $(0.76) [1] - The company expects sales between $2.470 billion and $2.587 billion, surpassing estimates of $2.548 billion [1] Strategic Outlook - The CEO of Teladoc Health, Chuck Divita, expressed optimism about the company's progress in 2025, highlighting that consolidated revenue and adjusted EBITDA were above the midpoint of guidance ranges for the fourth quarter [2] - The company has made advancements in its product portfolio and innovation across Integrated Care and BetterHelp, positioning itself for continued momentum in 2026 [2] Market Reaction - Following the earnings report, Teladoc Health shares increased by 13.5%, trading at $5.28 [3]